Supreme Court denies bid to send Texas abortion law case back to federal judge

Health, Fitness & Food

Pro-choice demonstrators rally outside the U.S. Supreme Court on November 01, 2021 in Washington, DC.
Drew Angerer | Getty Images

The Supreme Court on Thursday denied a request from Texas abortion providers to immediately send their case challenging the state’s strict abortion law back to a lower court.

Doing so would have allowed the abortion providers and advocates to proceed more quickly with their case against the law, which bans most abortions in Texas after as early as six weeks of pregnancy.

The high court in December said that a lawsuit against the ban could proceed, while keeping the law in effect.

Opponents of the ban wanted the case to return to a federal district court. On Monday, the U.S. Court of Appeals for the 5th Circuit sent the case to the Republican-controlled Texas Supreme Court, and it is unclear how soon that court will take it up.

The U.S. Supreme Court’s Thursday afternoon order denied the abortion providers’ request to compel the 5th Circuit to return the case to the district court.

The three liberal justices on the nine-member bench dissented to the order.

“Instead of stopping a Fifth Circuit panel from indulging Texas’ newest delay tactics, the Court allows the State yet again to extend the deprivation of the federal constitutional rights of its citizens through procedural manipulation,” Justice Sonia Sotomayor wrote in her dissent, joined by Justices Stephen Breyer and Elena Kagan.

“The Court may look the other way, but I cannot,” Sotomayor wrote.

This is breaking news. Please check back for updates.

Products You May Like

Articles You May Like

The WNBA Season May Be Over, But Unrivaled Basketball Is Just Getting Started
Op-ed: The financial toxicity of cancer is growing. Here’s what can be done to reduce it
Jake Dupree’s Cardio-Barre Remix Will Fire Up Your Glutes and Obliques
How to Stop Doomscrolling, According to Mental Health Experts
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034

Leave a Reply

Your email address will not be published. Required fields are marked *